Ultrasound guided percutaneous transluminal angioplasty for arteriovenous fistula and graft stenosis -----A 6-years clinical observation

医学 动静脉瘘 狭窄 经皮 血液透析 超声波 瘘管 外科 单中心 血管成形术 内科学 心脏病学 放射科
作者
Xiaoying Li,Song Chen,Chang Liu,Xin Wu,Yafei Tian,Chao Deng,Fengyi Fan,Xiaomei Wang,Tianyang Gui,Lili Guo,Yanyun Pan
出处
期刊:Research Square - Research Square
标识
DOI:10.21203/rs.3.rs-2055914/v1
摘要

Abstract Background: Percutaneous transluminal angioplasty(PTA) is the preferred treatment of vascular stenosis in arteriovenous fistula(AVF) and arteriovenous graft(AVG) in maintenance hemodialysis(MHD) patients. We observed the efficacy and influencing factors of PTA guided by Ultrasound in the treatment of AVF and AVG in our center. Methods: The data of PTA patients under the guidance of Ultrasound in our center from September 2015 to September 2021 were collected. 284 AVF patients and 83 AVG patients met the inclusion criteria, clinical indicators, postoperative use time and patency rate of the two groups were compared, and multiple linear regression analysis was used to compare the factors affecting the postoperative use time of the two groups. Results: The use time before (17.0(3.0, 64.6) vs 10.0(1.0, 27.9)) and after (9.0(2.0, 37.8) vs 6.0(1.0, 24.0)) PTA and high density lipoprotein concentration(1.36±0.36 vs 1.06±0.32) in AVF group were significantly higher than those in AVG group( P <0.05), and fibrinogen(4.03(2.78,6.22) vs 4.7(3.4,6.6)), blood phosphorus(1.33±0.48 vs 1.58±0.39), iPTH(408.15(22.13,1084.91) vs 509.7(83.03,1228.8)), total cholesterol(5.24±1.39 vs 5.64±1.42) and very low density lipoprotein concentration(0.51±0.27 vs 0.69±0.17) in AVF group were significantly lower than those in AVG group. The patency rates at 3, 6, 12, 24 months of AVF patients were 94.7%, 77.1%, 28.5%, 8.5%, and the patency rates at 3, 6, 12, 24 months of AVG patients were 88.0%, 54.2%, 18.1%, 3.6% respectively. Kaplan-meier analysis showed that the postoperative patency rate of AVF was significantly higher than that of AVG( P <0.05). In AVF group, the postoperative use time of PTA was related to primary disease, gender and platelet distribution width( P <0.05), while the postoperative use time of PTA was related to gender and eosinophil in AVG group( P <0.05). Conclusion: PTA guided by Ultrasound can effectively treat AVF/AVG stenosis, which causes minimum surgical trauma and can save precious vascular resources for MHD patients, this procedure is worthy of further promotion in clinical practice.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
云辞忧完成签到,获得积分10
1秒前
1秒前
强健的擎宇完成签到,获得积分10
2秒前
thomas完成签到,获得积分10
4秒前
英俊的铭应助丫头采纳,获得10
4秒前
上官若男应助研友_8QxN1Z采纳,获得10
4秒前
怕黑冰烟完成签到 ,获得积分10
5秒前
Jenny_Tseng完成签到,获得积分10
5秒前
5秒前
5秒前
泉竹晓筱完成签到,获得积分10
5秒前
量子星尘发布了新的文献求助10
6秒前
荔枝完成签到,获得积分10
6秒前
优雅含莲完成签到 ,获得积分10
6秒前
lmmorz完成签到,获得积分10
6秒前
刘耀威完成签到,获得积分20
7秒前
8秒前
诸熠晖发布了新的文献求助100
8秒前
8秒前
7ccc完成签到,获得积分10
8秒前
JamesPei应助XXXXX采纳,获得10
9秒前
荔枝发布了新的文献求助10
9秒前
9秒前
明理的易巧完成签到,获得积分20
9秒前
大模型应助派大星采纳,获得30
9秒前
9秒前
坦率笑天完成签到,获得积分10
9秒前
10秒前
猪猪hero发布了新的文献求助10
10秒前
星辰大海应助从容苡采纳,获得10
11秒前
生动成危发布了新的文献求助10
12秒前
大个应助PBB采纳,获得10
12秒前
刘耀威发布了新的文献求助10
13秒前
cyz完成签到,获得积分10
13秒前
ding应助古娜拉黑暗之神采纳,获得30
13秒前
云云应助从容的迎蓉采纳,获得10
13秒前
Stormi完成签到,获得积分10
14秒前
14秒前
小马甲应助清风荷影采纳,获得10
14秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Kinesiophobia : a new view of chronic pain behavior 2000
Burger's Medicinal Chemistry, Drug Discovery and Development, Volumes 1 - 8, 8 Volume Set, 8th Edition 1800
Cronologia da história de Macau 1600
文献PREDICTION EQUATIONS FOR SHIPS' TURNING CIRCLES或期刊Transactions of the North East Coast Institution of Engineers and Shipbuilders第95卷 1000
BRITTLE FRACTURE IN WELDED SHIPS 1000
Lloyd's Register of Shipping's Approach to the Control of Incidents of Brittle Fracture in Ship Structures 1000
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 纳米技术 计算机科学 化学工程 生物化学 物理 复合材料 内科学 催化作用 物理化学 光电子学 细胞生物学 基因 电极 遗传学
热门帖子
关注 科研通微信公众号,转发送积分 6146202
求助须知:如何正确求助?哪些是违规求助? 7973031
关于积分的说明 16561891
捐赠科研通 5257440
什么是DOI,文献DOI怎么找? 2807111
邀请新用户注册赠送积分活动 1787659
关于科研通互助平台的介绍 1656549